Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.79 |
| ▸ | RAB9A | P51151 | 9/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.79 |
| ▸ | NPC1 | O15118 | 7/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.79 |
| ▸ | LMNA | P02545 | 4/20 | 0.79 |
| ▸ | QSOX1 | O00391 | 1/20 | 0.79 |
| ▸ | PKM | P14618 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.78 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.78 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | USP2 | O75604 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 8/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18737213 | 0.90 | RAB9A (0.79) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL18641345 | 0.88 | RAB9A (1.00) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL13856556 | 0.88 | MAPT (1.00) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL8292347 | 0.86 | MAPT (0.97) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL10090719 | 0.84 | MAPT (0.79) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL22495299 | 0.82 | RAB9A (0.90) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL4256420 | 0.81 | RAB9A (0.78) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL4251117 | 0.80 | MAPT (0.76) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL22495349 | 0.77 | RAB9A (0.81) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL22495277 | 0.77 | RAB9A (0.81) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160166553-A1 | ANTIMETASTATIC COMPOUNDS | UNIV BRIGHAM YOUNG (US) | 2016-06-16 | — | — | US | disclosed |
| US-20130158035-A1 | ANTIMETASTATIC COMPOUNDS | BRIGHAM YOUNG UNIVERSITY (US) | 2013-06-20 | — | — | US | disclosed |
| WO-2012027392-A2 | ANTIMETASTATIC COMPOUNDS | BRIGHAM YOUNG UNIVERSITY (US) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158035-A1 | ANTIMETASTATIC COMPOUNDS | MET, HGFAC, HGF | MAPT 4206/4885RAB9A 2160/4885ALDH1A1 855/4885 |
| US-20160166553-A1 | ANTIMETASTATIC COMPOUNDS | MET, HGFAC, HGF | MAPT 4206/4885RAB9A 2160/4885ALDH1A1 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.